Krystal Submits Investigational New Drug Application for KB103 Topical Gene Therapy Candidate for Dystrophic Epidermolysis Bullosa Genetics Investing
Altimmune Announces Positive Data From Its Phase 2a Study of NasoVAX Intranasal Influenza Vaccine and Provides an Update Pharmaceutical Investing
Moleculin Enters Agreement with Seidman Cancer Center to Conduct Leukemia Clinical Trials Pharmaceutical Investing
Loxo Oncology Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration Genetics Investing
Organovo Division Samsara Sciences Announces Multi-Year Supply Agreement With Lonza Bioscience Solutions Biotech Investing
Amicus Therapeutics Announces Approval of Galafold® (Migalastat) for Fabry Disease in Japan Pharmaceutical Investing
Vericel Reports Publication from the Phase 3 SUMMIT Extension Study Demonstrating Sustained Clinical Benefit Genetics Investing
OPKO Health Enrolls First Patient in Phase 2b Study of OPK88003 to Treat Type 2 Diabetes Genetics Investing
Cesca Therapeutics Announces Financial Results for the Transition Period July 1, 2017 to December 31, 2017 Genetics Investing